Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412

Published:2010-01 Issue:1-2 Volume:352 Page:1-12
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Findlay Lucy,Eastwood David,Stebbings Richard,Sharp Giles,Mistry Yogesh,Ball Christina,Hood John,Thorpe Robin,Poole Stephen

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference14 articles.

1. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases;Beyersdorf;Ann. Rheum. Dis.,2005

2. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy;Chung;Oncologist,2008

3. Expert Group on Phase One Clinical Trials (Chairman: Professor Gordon W. Duff),2006

4. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens;Givan;J. Immunol. Methods,1999

5. Lessons from TGN1412;Hanke;Lancet,2006

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Living in LALA land? Forty years of attenuating Fc effector functions;Immunological Reviews;2024-08-19

2. Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study;Scientific Reports;2024-06-04

3. CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy;Blood;2024-05-23

4. A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody;Scientific Reports;2024-05-09

5. Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety;Journal of Visualized Experiments;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3